ismrm system phantomamos3.aapm.org/abstracts/pdf/90-25344-339462-107446.pdf · 2014-07-24 ·...
TRANSCRIPT
7/21/2014
1
National Institute of Standards and Technology
(NIST) Quantitative Imaging Initiatives Stephen Russek
Project Leader: Biomagnetic Imaging Standards, NIST, Boulder, CO
NIST Boulder
NIST Gaithersburg
F2 time standard
Josephson junction
voltage standard
AAPM MO-C-12A-6 July 21, 2014
Outline
1. Role of NIST
2. NIST Medical Imaging Standards: what's new • Ionizing radiation standards (Radiation Physics Division)
CT / PET phantoms
• Optical imaging standards
• Computational standards (Information Technology Lab)
Virtual/ numerical phantoms
3. MRI standards/ phantoms (Electromagnetics Division) • NIST/ISMRM MRI system phantom
• NIST/USCF breast phantom
• NIST/RSNA QIBA isotropic diffusion phantom (Mike Boss
TU-C-12A-8 Tuesday 10:15AM)
NIST’s Role in Quantitative Medical Imaging
Professional
Societies
Universities
Clinical Sites
Pharma
Venders
NIH
FDA
NIST
• Standard reference materials (SRMs)
• Standard reference artifacts (phantoms)
• Enabling traceability
• Establishment of “ground truth”
• Long term monitoring
• Measurement development/ basic
metrology research
• Setting standards, most standards are
consensus
• Phantom mass production
• Moving very fast
We are good at:
Not good at:
NIST is a National Metrology Institute: measurement & standards
7/21/2014
2
Safety based standards
Evolution of NIST medical imaging standards
1920 1930 1940 1950 1960 1970 1980 1990 2000 2010
NIST radiation
dose standards
Mammography
Quality Standards Act
NIST Metrology
PET/CT & MRI
Imaging as a Biomarker: Standards for
Change Measurements in Therapy
Workshop Summary
September 14-16, 2006,Laurence Clarke
Ram D. Sriram NISTIR 7434
Congressionally
funded NIST
imaging initiatives
Imaging as quantitative
measurement of biomarkers
Patient Protection and
Affordable Care Act
Metrology for Computed Tomography (CT)
• Calorimetry-based dosimetry (MO-E-17A-12)
• SRMs with calibrated attenuation coefficients
• Simple dimensional phantoms
SRM 2088 Density
Standard for Medical
Computed Tomography Heather Chen-Mayer at the
PET/CT scanner with HDPE
phantoms.
Foam lung
mimics
SRM 2087 Dimensional
Standard for Medical
Computed Tomography
Z.H. Levine
Brian Zimmerman
sta
ndard
s
sta
ndard
s
7/21/2014
3
Brian Zimmerman
PET Phantoms Brian Zimmerman
• Monitor scanner performance during clinical trials
• Comparison across scanners and clinical sites
• Accuracy of reconstruction and
scatter/attenuation corrections
Standard uncertainty on activity ~ 1 % Compatible with Jaczszak or ACR IQ phantoms
68Ge in epoxy cylinders
Optical coherence tomography: Near-IR 3d
imaging technique that collects scattered light that
reveals sub-surface features, 1mm resolution
Optical Medical Imaging Program at NIST
*instrument is currently in demo mode
Fast
tunable white
light laser source
Calibrated Hyperspectral imaging: imaging with a palette of 100s of contiguous spectral
bands. Each pixel has a full spectrum and can reveal
chemical information about a region.
Tissue Oximetric
Imaging ( surgery, combat and
diabetic wounds)
[Hb
O2]/
[Hb
]
Jeeseong Hwang, David Allen, Toni Litorja (PML) Antonio Possolo (ITL)
Emerging Application Areas:
NIST Workshop on “Standards for the Advancement of Optical Medical
Imaging,” August 26-27, 2014 NIST Gaithersburg, Maryland
“Wet” and digital
phantoms
7/21/2014
4
Virtual/ numerical phantom for modeling clinical tumors
Adele Peskin, Alden Dima, Charles Fenimore, James Filliben, Joseph Chen, Richard Rivello (Information Technology Laboratory)
Realistic CT lung tumor data (virtual phantom) with known tumor volumes based on clinical tumors
Embed synthetic tumors in DICOM data sets from NCI RIDER at two time points to determine accuracy of volume change measurements
Clinical tumor
Synthetic tumor
Tumor +
blood vessels
vascular/
partial volume
NV lung tissue
Pixel value (Hounsfield units) Peskin Lecture Notes in Computer Science
(LNCS) series pp. 736 - 746 2010
NIST/ISMRM MRI System Phantom
Measures: • Geometric distortion, B1 uniformity, B0 uniformity, T1, T2,
Proton density, resolution, slice thickness, SNR
Purpose: Scanner QC and inter-scanner comparison, verify T1
T2 mapping protocols, off-the-shelf validation for some clinical trials
First MRI phantom
with NIST traceability,
temperature and field
corrections, stability
monitoring
MRI Phantoms: must cover large parameter space
T1 Array
T2 Array
PD Array
100 100010
100
1000
Connective
CSF
Fat
Glial Matter
Kidney
LiverMuscle
Skin
White Matter
Liver Skeletal muscle Heart
Kidney
Cartilage 0°
Cartilage 55°
White matter
Gray matter
Optic nerve Spinal cord
Blood
10%
25%
40%
Olive oil
Heavy mineral oil
Fat mimic
Fibroglandular mimic
Fiducial Array
NiCl2 array
T2
(m
s)
T1(ms)
T2-T1 plot @ 1.5T for:
NiCl2 & MnCl
2 array @ 20C
and selection of tissues @ 37 C
MnCl2 array
contrast enhanced
PVP
• Phantoms contain
materials with well
defined parameters!
• Many other dimensions
required to mimic tissue:
diffusion, conductivity,
susceptibility!
7/21/2014
5
T1-Inversion Recovery gold standard:
Need to understand variability
17 18 19 20 21 22 23 24 25 26 27 280.57
0.58
0.59
0.60
0.61
0.62
0.63
0.64
0.65
r1 (
1/s
)
Temperature (C)
NiCl2 @ 1.5 T
5%
• Need in-situ thermometry for
accurate phantom measurement
comparisons.
• Arrays have large ranges with
short and long T1s, T2s that can
be challenging to measure
Katy Keenan
10 100 1000-20
-15
-10
-5
0
5
10
15
20
Err
or
(%)
Target T1 relaxation time (ms)
NIST 1.5 T 20.12 C 11TI
MDACC 1.5T-11TI
MGH 1.5T-12TI
Cin 1.5T-6TI
MGH 3TB6-11TI
MGH 3TB4-10TI
CUINC3T-9TI
UCD BIC 3T-10TI
Error = 100*(T1measured
-T1)/T1
272.9 4.1 ms
CoV=1.5%
T1 Variable Flip Angle: Large variations in
practical mapping sequences
NIST/ISMRM
system phantom
T1 array
Katy Keenan
Standard protocol:
7 flip angles
NIST/UCSF Universal Breast Phantom
Katy Keenan NIST, Nola Hilton UCSF
• For ACRIN 6698/ISPY 2 DWI Biomarkers
for Assessment of Breast Cancer
Response to Neoadjuvant Treatment
• T1, diffusion, geometric distortion, and
tissue mimics
normal
benign
malignant
7/21/2014
6
Do precise measurements of NMR parameters
make sense in tissue?
MRI measures apparent T1,
apparent T2 and apparent
diffusion coefficient!
T2 of olive oil used in
breast phantom
Need pragmatic but
rigorous definitions?
TE (s)
sig
nal
Many peaks each
with its own T1, T2
Mike Boss
CPMG (NMR)
SE (NMR/MRI)
FSE (MRI)
Breast Phantom: T2 ground truth?
Material
1.5 T 3.0 T
MRI Multi-Echo Spin
Echo
NMR CPMG*
t = 1.0ms
NMR Multi-Echo Spin
Echo* TE=15ms
NMR CPMG*
2.26 mM NiCl2 & 0.25 mM MnCl2 in water
55 ms 57.8 ms 39.0 ms 38.8 ms
35% w/w Corn Syrup in water
261 ms 266 ms 47.3 ms 84.7 ms
Grapeseed Oil
40 ms 160 ms 32.5 ms 171.8 ms
MRI measurements at 16.5 deg C. NMR measurements at ~20 deg C. * Integrated over all peaks
Spin echo includes chemical exchange r2 Dw2 B02
Mike Boss/ Katy Keenan
SI traceability for MRI?
•Traceability in MRI not established
(exception dimensional traceability through
optical interferometry)
•composition traceability for Ni and Mn
concentrations NIST Nickel SRM 3136 and
Manganese SRM 3132 Standard Solutions using
inductively coupled plasma optical emission
spectroscopy (ICPOES).
• NIST can offer traceable measurements of T1,
T2, ADC, susceptibility … using calibrated
variable field, variable temperature NMR ,
magnetometry if we can agree on suitable
definitions!
directly traceability to NIST
PET dose calibrator
System phantom reference
libraries
phantom reference libraries
7/21/2014
7
NIST Perspective/ Goals
• NIST is ramping up biomedical imaging standards for
quantitative biomarkers
• Goal: extend precise traceable measurements inside the
human
• Assist developing/ validation MR phantoms: anisotropic
diffusion, active flow/perfusion
• NIST will help facilitate a roadmap for standards for
quantitative MR
• NIST will investigate a study of economic impact of
standards-based quantitative MR
Workshop on Standards for Quantitative MR
NIST Boulder July, 2014
NIST MRI standards team: Mike Boss, Katy Keenan, Karl Stupic